Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04835805
Title A Study to Evaluate the Safety and Activity of Belvarafenib as a Single Agent and in Combination With Either Cobimetinib or Cobimetinib Plus Atezolizumab in Patients With NRAS-mutant Advanced Melanoma.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Genentech, Inc
Indications

skin melanoma

Therapies

Atezolizumab

Belvarafenib + Cobimetinib

Atezolizumab + Belvarafenib + Cobimetinib

Age Groups: adult | senior
Covered Countries USA | CAN

Additional content available in CKB BOOST